Circulating anticoagulants: physiologic and pathophysiologic.
D000990:Antithrombin III / Q000502:physiology; D020152:Antithrombin III Deficiency; D001778:Blood Coagulation Disorders / Q000097:blood*; D001779:Blood Coagulation Factors / Q000502:physiology*; D005165:Factor V / Q000502:physiology; D005169:Factor VIII / Q000502:physiology; D005170:Factor X / Q000502:physiology; D005172:Factor XI / Q000502:physiology; D006023:Glycoproteins / Q000502:physiology; D006467:Hemophilia A / Q000097:blood; D002836:Hemophilia B / Q000097:blood; D006801:Humans; D011486:Protein C; D000515:alpha 1-Antitrypsin / Q000502:physiology; D000511:alpha-Macroglobulins / Q000502:physiology; D014842:von Willebrand Diseases / Q000097:blood
D001779:Blood Coagulation Factors; D006023:Glycoproteins; D011486:Protein C; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; D000990:Antithrombin III; D005165:Factor V; D005169:Factor VIII; D005170:Factor X; D005172:Factor XI